CAL
RXST icon

Capital Advisors Ltd’s RxSight RXST Stock Holding History

Capital Advisors Ltd’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-71
Closed -$1K – 1543
2025
Q3 		$1K Buy
71
+42
+145% +$369 ﹤0.01% 1278
2025
Q2 		$0 Hold
29
– – ﹤0.01% 1598
2025
Q1 		$1K Hold
29
– – ﹤0.01% 1262
2024
Q4 		$1K Hold
29
– – ﹤0.01% 1291
2024
Q3 		$1K Hold
29
– – ﹤0.01% 1285
2024
Q2 		$2K Hold
29
– – ﹤0.01% 1082
2024
Q1 		$1K Hold
29
– – ﹤0.01% 1262
2023
Q4 		$1K Hold
29
– – ﹤0.01% 1214
2023
Q3 		$1K Hold
29
– – ﹤0.01% 1207
2023
Q2 		$1K Hold
29
– – ﹤0.01% 1212
2023
Q1 		$0 Hold
29
– – ﹤0.01% 1509
2022
Q4 		$0 Buy
+29
New +$353 ﹤0.01% 1579

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Capital Advisors Ltd's RXST Position: Q4 2025 in Review

Capital Advisors Ltd sold out of RxSight (RXST) in Q4 2025, closing a stake of 71 shares — an estimated $1K sold.

Capital Advisors Ltd first reported a position in RXST in Q4 2022 and held it in 12 quarters. The position peaked at $2K in Q2 2024. 163 funds tracked by Wall St. Rank hold RXST as of Q4 2025.

  • Capital Advisors Ltd reported no remaining RxSight position as of Q4 2025 after selling out during the quarter.
  • Capital Advisors Ltd sold 71 RxSight shares in Q4 2025, an estimated $1K.
  • Capital Advisors Ltd first reported a position in RxSight in Q4 2022 and held it in 12 quarters.
  • Capital Advisors Ltd's RxSight position peaked at $2K in Q2 2024.
  • 163 funds tracked by Wall St. Rank held RxSight as of Q4 2025.

Based on Capital Advisors Ltd's 13F filing for Q4 2025, filed 21 Jan 2026.